Docetaxel in stage III and IV non-small cell lung cancer
- 31 October 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31, S18-S20
- https://doi.org/10.1016/0959-8049(95)00358-p
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Phase II trial of docetaxel in patients with stage III and IV non-small-cell lung cancer.Journal of Clinical Oncology, 1994
- A Randomized Trial Comparing Perioperative Chemotherapy and Surgery With Surgery Alone in Resectable Stage IIIA Non-Small-Cell Lung CancerJNCI Journal of the National Cancer Institute, 1994
- Cancer in developing countriesCA: A Cancer Journal for Clinicians, 1994
- Cancer statistics, 1994CA: A Cancer Journal for Clinicians, 1994
- Phase I Trial of Taxotere: Five-Day ScheduleJNCI Journal of the National Cancer Institute, 1992
- Chemotherapy of non-small cell lung cancer according to disease extent: a meta-analysis of the literatureLung Cancer, 1991
- Relationships between the structure of taxol analogs and their antimitotic activityJournal of Medicinal Chemistry, 1991
- Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of TaxolJNCI Journal of the National Cancer Institute, 1991
- Application of the vicinal oxyamination reaction with asymmetric induction to the hemisynthesis of taxol and analoguesTetrahedron, 1989
- Highly efficient, practical approach to natural taxolJournal of the American Chemical Society, 1988